Compare Rockwell Automation (ROK) vs Revvity Inc (RVTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Rockwell Automation vs Revvity Inc — how do they compare? Rockwell Automation trades at $425.63 (market cap $47.32B), while Revvity Inc trades at $124.14 (market cap $13.82B). The key difference: Rockwell Automation is far larger — about 3.4× Revvity Inc's market cap, and Rockwell Automation pays the higher dividend (1.3%). Which is the better fit depends on your goals.
| ROK | RVTY | |
|---|---|---|
Market Cap | $47.32B | $13.82B |
Sector | Industrials | Technology |
52-Week High | $495.08 | $130.94 |
52-Week Low | $333.75 | $82.26 |
Enterprise Value | $50.45B | $16.14B |
Dividend Yield | 1.3% | 0.23% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Rockwell Automation (ROK) trades at $429.13, down 1.08% on the day, with a bearish technical signal and mixed sentiment. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $3.49 exceeding expectations, but faces declining profit margins from 14.1% in 2023 to 10.41% in 2025. Analyst consensus is a Buy with a $514 price target, though technical indicators show resistance near $434 and support at $427.
The stock offers upside based on analyst targets and robust cash flow, but risks include margin pressure, high valuation multiples, and macroeconomic sensitivity. Institutional interest remains positive with recent investments, but investors should weigh the bearish technical trend against fundamental strengths in industrial automation demand.
RVTY trades at $127.08, down 2.41% over 24 hours, with a bullish technical signal driven by moving averages and strong support at $126. The company reported Q2 2026 EPS of $1.41, beating estimates, and raised its full-year outlook, supported by diagnostics growth and improved cash flow. Recent news includes the acquisition of Human Cell Design and product launches, indicating strategic expansion.
Outlook remains positive with a consensus price target of $136.20, offering ~7% upside, but high P/E of 59.54 poses valuation risk. Key opportunities include earnings momentum and innovation; risks involve premium valuation and competitive pressures in the healthcare sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Rockwell Automation
Rockwell Automation is a pure-play automation competitor that is the successor entity to Rockwell International, which spun off its former Rockwell Collins avionics segment in 2001. As of fiscal 2021, the firm operates through three segments--intelligent devices, software and control, and lifecycle services. Intelligent devices contains its drives, sensors, and industrial components, software and control contains its information and network and security software, while lifecycle services contains its consulting and maintenance services as well as its Sensia JV with Schlumberger.
Read more on ROK →About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →
